Mountain West AIDS Education and Training Center (MWAETC)

OD presentation return node

« Return to MWAETC On-Demand Presentations

Revisiting Cardiovascular Risks of Abacavir: Insights from the REPRIEVE Trial

Presentation Date: 2025-05-15

Presentation Length: 19:24

Presenters: Jimmy Ma, MD, MS

Presentation Categories: HIV ECHO

Presentation Tags: Anti-Retroviral Therapy (ART)

Presentation Slides:

Download (483.502 KB)

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
Dr. Jimmy Ma reviews the latest data on cardiovascular risks of the antiretroviral medication abacavir, including findings from the REPRIEVE trial, and discusses how these findings might affect HIV treatment decisions.

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.